(NASDAQ: FRMM) Forum Markets's forecast annual revenue growth rate of 121.41% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 48.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.87%.
Forum Markets's revenue in 2026 is $9,406,000.On average, 5 Wall Street analysts forecast FRMM's revenue for 2026 to be $278,265,360, with the lowest FRMM revenue forecast at $256,538,150, and the highest FRMM revenue forecast at $308,456,585. On average, 5 Wall Street analysts forecast FRMM's revenue for 2027 to be $678,924,432, with the lowest FRMM revenue forecast at $453,304,655, and the highest FRMM revenue forecast at $870,397,293.
In 2028, FRMM is forecast to generate $1,053,551,571 in revenue, with the lowest revenue forecast at $727,527,067 and the highest revenue forecast at $1,389,581,643.